Endocrinology, Vol 127, 1910-1915, Copyright © 1990 by Endocrine Society

ARTICLES

Transforming growth factor-beta inhibits steroid 17 alpha-hydroxylase cytochrome P-450 expression in ovine adrenocortical cells

WE Rainey, D Naville, JM Saez, BR Carr, W Byrd, RR Magness and JI Mason
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75235.

The maintenance of optimal steroidogenesis in adrenocortical cells primarily depends on the chronic action of ACTH to promote the synthesis of the various steroid-metabolizing cytochrome P-450 enzymes. In the steroidogenic pathway, 17 alpha-hydroxylase cytochrome P-450 (P- 450(17) alpha) is a key enzyme controlling the formation of cortisol and androgens. Recently, we demonstrated that transforming growth factor-beta (TGF beta) is a potent inhibitor of steroid production in ovine adrenocortical cells. In the present study we used a polyclonal antibody to P450(17) alpha to determine adrenal cell P-450(17) alpha enzyme content by Western analysis. In addition, we used a cDNA probe encoding for bovine P-450(17) alpha mRNA to determine levels of P- 450(17) alpha mRNA in sheep ovarian adrenocortical cells in primary culture. When cells were cultured in a serum-free medium in the presence of ACTH for 48 h, P-450(17) alpha activity, enzyme content, and mRNA levels for P-450(17) alpha increased by 3- to more than 10- fold. TGF beta decreased the basal level and completely blocked the stimulatory action of ACTH on P-450(17) alpha enzyme activity. The effects of TGF beta on P-450(17) alpha enzyme content and mRNA levels were manifested in a dose-dependent manner, with maximal inhibition observed using 1 ng/ml TGF beta. Importantly, the inhibitory effects of TGF beta on P-450(17) alpha were not overcome by (Bu)2cAMP. These findings indicate that TGF beta is a potent negative regulator of P- 450, and the inhibitory action appears to be at the level of P-450(17) alpha gene expression. The ability of TGF beta to suppress the positive stimulatory action of ACTH suggests that TGF beta could play a role in determining the pathway of steroidogenesis and, thereby, the specific steroids secreted by adrenocortical cells.

This article has been cited by other articles:

				M Cutolo, C M Montecucco, L Cavagna, R Caporali, S Capellino, P Montagna, L Fazzuoli, B Villaggio, B Seriolo, and A Sulli Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis Ann Rheum Dis, November 1, 2006; 65(11): 1438 - 1443. [Abstract] [Full Text] [PDF]

				C. L. Coulter, I. C. McMillen, I. M. Bird, and M. D. Salkeld Steroidogenic Acute Regulatory Protein Expression Is Decreased in the Adrenal Gland of the Growth-Restricted Sheep Fetus During Late Gestation Biol Reprod, August 1, 2002; 67(2): 584 - 590. [Abstract] [Full Text] [PDF]

				K. Inoue, K. Nakamura, K. Abe, T. Hirakawa, M. Tsuchiya, H. Matsuda, K. Miyamoto, and T. Minegishi Effect of Transforming Growth Factor {beta} on the Expression of Luteinizing Hormone Receptor in Cultured Rat Granulosa Cells Biol Reprod, August 1, 2002; 67(2): 610 - 615. [Abstract] [Full Text] [PDF]

				X.-L. Wang, M. Bassett, Y. Zhang, S. Yin, C. Clyne, P. C. White, and W. E. Rainey Transcriptional Regulation of Human 11{beta}-Hydroxylase (hCYP11B1) Endocrinology, October 1, 2000; 141(10): 3587 - 3594. [Abstract] [Full Text] [PDF]

				R. H. Straub, T. Gluck, M. Cutolo, J. Georgi, K. Helmke, J. Scholmerich, P. Vaith, and B. Lang The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica Rheumatology, June 1, 2000; 39(6): 624 - 631. [Abstract] [Full Text] [PDF]

				C. Le Roy, J. Y. Li, D. M. Stocco, D. Langlois, and J. M. Saez Regulation by Adrenocorticotropin (ACTH), Angiotensin II, Transforming Growth Factor-{beta}, and Insulin-Like Growth Factor I of Bovine Adrenal Cell Steroidogenic Capacity and Expression of ACTH Receptor, Steroidogenic Acute Regulatory Protein, Cytochrome P450c17, and 3{beta}-Hydroxysteroid Dehydrogenase Endocrinology, May 1, 2000; 141(5): 1599 - 1607. [Abstract] [Full Text] [PDF]

				M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis Endocr. Rev., April 1, 1998; 19(2): 101 - 143. [Abstract] [Full Text]

				C. Brand, N. Cherradi, G. Defaye, A. Chinn, E. M. Chambaz, J.-J. Feige, and S. Bailly Transforming Growth Factor beta 1 Decreases Cholesterol Supply to Mitochondria via Repression of Steroidogenic Acute Regulatory Protein Expression J. Biol. Chem., March 13, 1998; 273(11): 6410 - 6416. [Abstract] [Full Text] [PDF]

				K. J. Becker, R. M. McCarron, C. Ruetzler, O. Laban, E. Sternberg, K. C. Flanders, and J. M. Hallenbeck Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia PNAS, September 30, 1997; 94(20): 10873 - 10878. [Abstract] [Full Text] [PDF]

				C. Le Roy, P. Leduque, P. M. Dubois, J. M. Saez, and D. Langlois Repression of Transforming Growth Factor beta1 Protein by Antisense Oligonucleotide-induced Increase of Adrenal Cell Differentiated Functions J. Biol. Chem., May 3, 1996; 271(18): 11027 - 11033. [Abstract] [Full Text] [PDF]